PORTLAND, Maine — Putney, a pharmaceutical company focused on the development of generic drugs for pets, has launched carprofen caplets, a bioequivalent generic version of the canine medication Rimadyl (Pfizer Animal Health) caplets.
Carprofen is widely used in dogs for the relief of pain and inflammation associated with osteoarthritis, as well as the control of postoperative pain associated with soft tissue and orthopedic surgeries.
Putney's carprofen caplets have demonstrated bioequivalence to Rimadyl caplets in an FDA-approved study and will be available in 25-mg, 75-mg and 100-mg caplets.
For more information, visit www.putneyvet.com.
NEXT:
Reader Forum (July 2009)